Safinamide Improves Mood in Parkinson´s Disease. Results from the SAFINONMOTOR StudySafinamide Improves Mood in Parkinson´s Disease. Results from the SAFINONMOTOR Study enero 12, 1919enero 12, 2023
Improves Non-Motor Symptoms Burden in Parkinson´s Disease: An Open-label Prospective Study enero 12, 1919enero 12, 2023
Non-Motor Symptoms Burden Groups in Parkinson´s Disease. Change after treatment with safinamide enero 12, 1919enero 12, 2023
Efectividad de safinamida sobre los síntomas no motores en la enfermedad de Parkinson. Análisis intermedio a los 3 meses del estudio SAFINONMOTOR (Webinar) enero 12, 1919enero 12, 2023
Effectiveness of Safinamide over Mood in Parkinson’s Disease Patients: Secondary Analysis of the Open-label Study SAFINONMOTOR enero 12, 1919enero 12, 2023
Pain Improvement in Parkinson´s Disease Treated wirh Safinamide. Results from the SAFINONMOTOR Study enero 12, 1919enero 12, 2023
Safinamide Improves Non-Motor Symptoms Burden in Parkinson’s Disease: An Open-Label Prospective Study enero 12, 1919enero 12, 2023
Safinamide Improves Sleep and Daytime Sleepiness in Parkinson´s Disease. Results from the SAFINONMOTOR Study enero 12, 1919enero 12, 2023
Vortioxetina mejora el estado de ánimo y la función cognitiva en pacientes con enfermedad de Parkinson y depresión mayor. Resultados del estudio VOPARK. enero 12, 1919enero 12, 2023
Vortioxetine Improves Depressive Symptoms and Cognition in Parkinson’s Disease Patients with Major Depression: An Open-Label Prospective Study enero 12, 1919enero 12, 2023
